Building laboratory capacity to support HIV care in Nigeria: Harvard/APIN PEPFAR, 2004–2012

por Hamel, Donald J., Sankalé, Jean-Louis, Samuels, Jay Osi, Sarr, Abdoulaye D., Chaplin, Beth, Ofuche, Eke, Meloni, Seema T., Okonkwo, Prosper, Kanki, Phyllis J.
Publicado 2015

Early detection of Pre-XDR TB with line probe assay in a high TB burden country

por Madukaji, Laura, Okohu, Isaac, Usman, Saheed, Oyedum, Uche, Enagi, Abdullah, Usman, Abubakar, Adedeji, AS, Owolagba, Femi, Ofuche, Eke, Samuels, Jay Osi, Jolayemi, Toyin, Okonkwo, Prosper
Publicado 2021

The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation

por Ogbenna, Ann Abiola, Meloni, Seema, Inzaule, Seth, Hamers, Raph L., Sigaloff, Kim, Osibogun, Akin, Adeyemo, Titilope Adenike, Okonkwo, Prosper, Samuels, Jay Osi, Kanki, Phyllis J., Rinke de Wit, Tobias F., Akanmu, Alani Sulaimon
Publicado 2020

Low levels of HIV-1 drug resistance mutations in patients who achieved viral re-suppression without regimen switch: a retrospective study

por Onwuamah, Chika K., Okpokwu, Jonathan, Audu, Rosemary, Imade, Godwin, Meloni, Seema T., Okwuraiwe, Azuka, Chebu, Philippe, Musa, Adesola Z., Chaplin, Beth, Dalhatu, Ibrahim, Agbaji, Oche, Samuels, Jay, Ezechi, Oliver, Ahmed, Mukhtar, Odaibo, Georgina, Olaleye, David O., Okonkwo, Prosper, Salako, Babatunde Lawal, Raizes, Elliot, Yang, Chunfu, Kanki, Phyllis J., Idigbe, Emmanuel O.
Publicado 2020

Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options

por Meloni, Seema T, Onwuamah, Chika K, Agbaji, Oche, Chaplin, Beth, Olaleye, David O, Audu, Rosemary, Samuels, Jay, Ezechi, Oliver, Imade, Godwin, Musa, Adesola Z, Odaibo, Georgina, Okpokwu, Jonathan, Rawizza, Holly, Mu’azu, Muhammad A, Dalhatu, Ibrahim, Ahmed, Mukhtar, Okonkwo, Prosper, Raizes, Elliot, Ujah, Innocent A O, Yang, Chunfu, Idigbe, Emmanuel O, Kanki, Phyllis J
Publicado 2017